Drugs Made In America Acquisition II Corp. Right (NASDAQ: DMIIR) last traded at $0.0700, up 7.86% on the session. The quote above updates while this page is open; the figures below are drawn from Drugs Made In America Acquisition II Corp. Right’s own filings and are restated only when a new one is published.
Drugs Made In America Acquisition II Corp. Right trades on NASDAQ under the ticker DMIIR. Its market capitalisation is $4.46 million.
Valuation measures for Drugs Made In America Acquisition II Corp. Right, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.46M |
|---|---|
| Enterprise value | $22.43M |
Trailing-twelve-month figures tagged in Drugs Made In America Acquisition II Corp. Right's XBRL filings with the SEC.
| Net income (TTM) | $13.02M |
|---|---|
| Cash | $175.0K |
Range and volume for DMIIR over the past 52 weeks.
| 52-week high | $0.0700 |
|---|---|
| 52-week low | $0.0530 |
| Volume | 1.8K |
| Average volume | 1.8K |
| Previous close | $0.0649 |
Invest a chosen dollar amount in Drugs Made In America Acquisition II Corp. Right with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DMIIR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.